Cash Flow Statement
Growth Metrics

Mimedx (MDXG) Net Cash Flow Growth (3y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 89.97%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -13.44%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 33.37%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -29.82%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 32.17%
10 Mimedx 530.69 Mn 370.92 Mn 41.62 Mn -10.31%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -10.31%
Dec 31, 2025 108.45%
Sep 30, 2025 219.02%
Jun 30, 2025 80.89%
Mar 31, 2025 29.60%
Dec 31, 2024 51.09%
Sep 30, 2024 49.83%
Jun 30, 2024 334.98%
Mar 31, 2024 -44.68%
Dec 31, 2023 27.25%
Sep 30, 2023 -41.16%
Jun 30, 2023 50.26%
Mar 31, 2023 32.74%
Dec 31, 2022 28.18%
Sep 30, 2022 31.13%
Jun 30, 2022 -26.96%
Mar 31, 2022 12.00%
Dec 31, 2021 -467.95%
Sep 30, 2021 98.13%
Jun 30, 2021 -75.56%
Mar 31, 2021 -121.23%
Dec 31, 2020 -40.44%
Sep 30, 2020 96.41%
Jun 30, 2020 -32.41%
Mar 31, 2020 -64.89%
Dec 31, 2019 -55.61%
Sep 30, 2019 19.92%
Jun 30, 2019 99.09%
Mar 31, 2019 -7.78%
Dec 31, 2018 26.10%
Sep 30, 2018 -33.71%
Jun 30, 2018 475.11%
Mar 31, 2018 49.39%
Dec 31, 2017 -95.11%
Sep 30, 2017 -50.00%
Jun 30, 2017 85.67%
Mar 31, 2017 -48.49%
Dec 31, 2016 -28.04%
Sep 30, 2016 -70.14%
Jun 30, 2016 97.22%
Mar 31, 2016 -135.06%
Dec 31, 2015 -143.87%
Sep 30, 2015 -20.75%
Jun 30, 2015 36.24%
Mar 31, 2015 -93.35%
Dec 31, 2014 -29.92%
Sep 30, 2014 116.83%
Jun 30, 2014 -102.92%
Mar 31, 2014 -48.96%